𝔖 Bobbio Scriptorium

✦ LIBER ✦

(766): A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful distal diabetic neuropathy

✍ Scribed by M. Bretschneider; S. Bongardt; B. Koch

Book ID: 119306995
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 39 KB
Volume: 7
Category: Article
ISSN: 1528-8447
DOI: 10.1016/j.jpain.2006.01.168

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

(774): A multi-center, randomized, doubl

(774): A multi-center, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of lacosamide (200, 400, and 600mg/day) in subjects with painful distal diabetic neuropathy

✍ P. Kenney; J. Simpson; B. Koch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 41 KB

1564 The efficacy and safety characteris

1564 The efficacy and safety characteristics of long-term pregabalin treatment of neuropathic pain (NeP) associated with diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN) in treatment-refractory patients: findings from an open-label trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Long-term safety and efficacy of linagli

Long-term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose-lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24-week phase III trials followed by a 78-week open-label extension

✍ R. Gomis; D. R. Owens; M.-R. Taskinen; S. Del Prato; S. Patel; A. Pivovarova; A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB